← Back to Clinical Trials
Recruiting NCT07137533

NCT07137533 Mandibular Overdentures vs All-on-4 With PEEK

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07137533
Status Recruiting
Phase
Sponsor Menoufia University
Condition Bone Loss in Jaw
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2025-08-01
Primary Completion 2025-10-01

Trial Parameters

Condition Bone Loss in Jaw
Sponsor Menoufia University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 40 Years
Max Age 70 Years
Start Date 2025-08-01
Completion 2025-10-01
Interventions
Mandibular Four-Implant-Retained Overdenture (PEEK Framework); Mandibular All-on-4 Fixed Prosthesis (PEEK Framework)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study compares long-term peri-implant outcomes between two mandibular full-arch rehabilitation approaches-four-implant-retained overdentures and All-on-4 fixed prostheses-when both are fabricated with polyetheretherketone (PEEK) frameworks. While overdentures and All-on-4 prostheses are widely used, evidence on the clinical performance of PEEK frameworks in these modalities is scarce. By evaluating marginal bone loss and other peri-implant parameters, the research aims to clarify whether prosthetic design influences biological outcomes when using this high-performance polymer.

Eligibility Criteria

Inclusion Criteria: Adults aged ≥40 years. Completely edentulous mandible for at least 6 months prior to implant placement. Treated with either: Four-implant-retained mandibular overdenture with a PEEK framework, or Mandibular All-on-4 fixed prosthesis with a PEEK framework. All implants placed in the lateral incisor and first premolar regions (per respective protocol). Restorations fabricated via CAD/CAM-milled PEEK framework with acrylic denture teeth. Prosthesis delivered with a delayed loading protocol. Minimum clinical and radiographic follow-up of 4 years. Availability of standardized baseline and follow-up periapical radiographs for marginal bone level assessment. Treated by the same surgical and prosthodontic team. Exclusion Criteria: History of uncontrolled systemic diseases that could affect bone healing (e.g., uncontrolled diabetes, osteoporosis under bisphosphonate therapy). History of head and neck radiotherapy. Active periodontal or peri-implant infection at the time of i

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology